Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT05795634
- Status
- Recruiting
Conditions
- Alzheimer Disease
- Mild Cognitive Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Trier Social Stress Test — BEHAVIORALAcute psychosocial stress procedure; 5 minutes of public speaking and 5 minutes of mental arithmetic
Study Details
The goal of this clinical trial is to learn about how genetics and the response to stress predicts cognitive decline in individuals with mild cognitive impairment. The main question\[s\] it aims to answer are: * Does the hormone response to acute stress predict the degree of cognitive impairment following acute stress? * Do genes associated with the risk for Alzheimer's disease influence the relationship between stress hormone response to stress and cognitive impairment following stress? * Do cognitive impairment following acute stress and genes associated with the risk for Alzheimer's disease predict cognitive decline and change in biomarkers for Alzheimer's disease 2 years later? Participants will have 3 in-person study visits. The first 2 will occur at baseline and the 3rd visit will occur 2 years later. During the visits, participants will provide blood and saliva samples, undergo a 10-minute social stress procedure, complete questionnaires, and take tests of memory and other thinking skills. Someone who knows the participant (a "study partner") will be asked questions about the participant's daily functioning at the first and 3rd study visits.
Key Dates
- Start date
- Mar 1, 2023
- Status verified
- Jan 2026
- Primary completion
- Mar 1, 2028
- Completion
- Mar 1, 2029
Study Design
- Enrollment
- 240 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Trier Social Stress TestAll participants in the study will get undergo the same stress procedure
Primary Outcome Measure
Change in mean memory test composite score [ Time Frame: Baseline and Visit 2 (up to 1 month) and Baseline to Visit 3 (up to 2 years) ]
Central Contacts
- Cynthia A Munro, PhD410-550-6271
- Nicholas Bienko, MS410-550-2036
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins School of Medicine | Baltimore | Maryland | 21224 |
Find similar trials in Baltimore, MD
Related Studies
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- Vestibular Therapy in Alzheimer's DiseaseRecruiting · Johns Hopkins University · Baltimore, Maryland
- Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseEARLY_PHASE1 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseasePHASE1 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland